Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Farmers Insurance
Cipla
Express Scripts
Chinese Patent Office
Dow
Teva
Argus Health

Generated: December 14, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Aldesleukin

« Back to Dashboard

US Patents for Aldesleukin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Aldesleukin ➤ Sign Up Devices and methods for local delivery of drug to upper urinary tract TARIS Biomedical LLC (Lexington, MA) ➤ Sign Up
Aldesleukin ➤ Sign Up IL-2R.beta.-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody Nektar Therapeutics (San Francisco, CA) ➤ Sign Up
Aldesleukin ➤ Sign Up TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs) YALE UNIVERSITY (New Haven, CT) ➤ Sign Up
Aldesleukin ➤ Sign Up Implantable medical devices for extended release of therapeutic agents Nano Precision Medical, Inc. (Emeryville, CA) ➤ Sign Up
Aldesleukin ➤ Sign Up Compositions comprising serum albumin and p53 peptides fusion proteins University of the Sciences of Philadelphia (Philadelphia, PA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Aldesleukin

Drugname Country Document Number Estimated Expiration Related US Patent
Aldesleukin European Patent Office 3277363 2035-03-30 ➤ Sign Up
Aldesleukin Japan 2018516096 2035-03-30 ➤ Sign Up
Aldesleukin South Korea 20170132189 2035-03-30 ➤ Sign Up
Aldesleukin World Intellectual Property Organization (WIPO) 2016160934 2035-03-30 ➤ Sign Up
Aldesleukin Australia 2015220408 1989-12-31 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Moodys
Medtronic
Citi
Federal Trade Commission
Covington
US Department of Justice
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.